Pharmacy

Illinois Gov. JB Pritzker signed a bill into law that will require insurers to cover the costs of EpiPen injectors for children, according to CNN. 

Genealogy company Ancestry is planning a push into healthcare, according to Business Insider.

The Institute for Clinical and Economic Review, a U.S. pricing watchdog, has proposed changing its evaluation process to better account for CAR-T and gene therapy prices, according to an S&P Global Market Intelligence report. 

U.S. Senate Finance Committee Chairman Chuck Grassley, R-Iowa, has asked Novartis to provide company records and details about data manipulation related to FDA approval of its $2 million gene therapy Zolgensma, according to EndPoints News.

An Oklahoma pharmacy owner has pleaded guilty to taking part in a $1.1 million scheme that defrauded health insurance providers, according to KFOR-TV.

Walmart soon will open a 1,500-square-foot retail space and pharmacy in a Toyota plant in Mississippi, according to the Daily Journal. 

Several drugs entered the U.S. market in 2019, some of which could generate at least $1 billion in annual sales by 2024, according to market research firm EvaluatePharma.

John O'Brien, the senior adviser to HHS Secretary Alex Azar on drug-pricing reform, will step down from his position Aug. 22.

Canadians, furious about the Trump administration's plan to allow the importation of their prescription drugs, are discussing several ways to stop the proposal, according to STAT.

Most insurers and pharmacy benefit managers haven't placed the cheaper version of insulin manufactured by Eli Lilly on their lists of covered drugs, according to the Financial Times.